TCR² THERAPEUTICS Trademark
TCR² THERAPEUTICS is a USPTO trademark filed by TCR2 Therapeutics Inc.. Status: Cancelled.
Trademark Facts
| Mark | TCR² THERAPEUTICS |
|---|---|
| Serial Number | 88174433 |
| Registration Number | 5892910 |
| Status | Cancelled |
| Filing Date | 2018-10-30 |
| Registration Date | 2019-10-22 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | TCR2 Therapeutics Inc. |
| Prosecution Events | 34 |
| Latest Event | C8.. on 2026-05-08 |
Goods & Services
Class 005: Biological and pharmaceutical preparations, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use in the nature of biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases; Class 042: Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics